ArticleNutrition journal2025
Association of diabetes risk reduction diet (DRRD) score with metabolic health, brain-derived neurotrophic factor and adropin in Iranian adults.
Article in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe connection between the diabetes risk reduction diet (DRRD) score and metabolic health is not exactly clear. This study examined the association between DRRD score and metabolic health (MH), serum adropin, and brain-derived neurotrophic factor (BDNF) in Iranian adults.
methodsThis cross-sectional investigation employed a sample of 527 adults (45.7% females) within the age range of 20 to 65 years, who were selected via a multistage cluster random sampling technique. Dietary assessment of participants was evaluated utilizing a validated food frequency questionnaire, while a fasting blood sample from each participant was procured to analyze biochemical parameters. MH status was ascertained according to the criteria delineated by Wildman et al. The DRRD score was calculated based on nine elements.
resultsAfter adjusting for potential confounders, no significant association was observed between higher DRRD score tertiles and odds of metabolically unhealthy status (OR = 0.99; 95% CI: 0.58–1.70). Individuals in the highest tertile of DRRD score demonstrated a 44% (95% CI: 0.33–0.96) significant reduction in the odds of developing hypertriglyceridemia compared to those in the lowest tertile. However, no significant reduction was observed in other Metabolically Unhealthy (MU) components. Also, no significant difference was observed in BDNF and adropin levels among individuals in DRRD score tertiles.
conclusionsA Higher DRRD score was associated with reduced odds of hypertriglyceridemia, but no significant associations were observed with other metabolic unhealthy components or BDNF and adropin levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.